Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NUS Stock Forecast 2025-2026
$7.58
Current Price
$369.12M
Market Cap
Buy 0
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to NUS Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
NUS Price Momentum
+10.8%
1 Week Change
+38.3%
1 Month Change
-44.5%
1 Year Change
+10.0%
Year-to-Date Change
-45.3%
From 52W High of $13.86
+42.5%
From 52W Low of $5.32
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Nu Skin (NUS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NUS and similar high-potential opportunities.
Latest NUS Stock Price Targets & Analyst Predictions
NUS has shown a year-to-date change of 10.0% and a 1-year change of -44.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for NUS. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NUS Analyst Ratings
0
Buy
1
Hold
0
Sell
NUS Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $7.58
Latest NUS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NUS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $7.00 |
| Oct 22, 2024 | Citigroup | Chasen Bender | Neutral | Maintains | $6.75 |
| Aug 12, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $11.00 |
| Aug 9, 2024 | Citigroup | Chasen Bender | Neutral | Maintains | $11.50 |
| May 9, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $12.50 |
| Jan 5, 2024 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $21.00 |
| Oct 16, 2023 | Stifel | Mark Astrachan | Hold | Maintains | $27.00 |
| Sep 29, 2023 | Citigroup | Chasen Bender | Neutral | Maintains | $23.00 |
| Aug 3, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Reiterates | $29.00 |
| Aug 2, 2023 | Stifel | Mark Astrachan | Hold | Maintains | $35.00 |
| May 19, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Reiterates | $38.00 |
| Mar 1, 2023 | Citigroup | Chasen Bender | Neutral | Maintains | $41.00 |
| Feb 16, 2023 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $38.00 |
| Jan 31, 2023 | Jefferies | Ashley Helgans | Hold | Downgrade | $39.00 |
| Nov 23, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $34.00 |
| Oct 5, 2022 | Citigroup | Chasen Bender | Neutral | Maintains | $39.00 |
| Aug 23, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $40.00 |
| Aug 8, 2022 | Citigroup | Chasen Bender | Neutral | Maintains | $47.00 |
| May 5, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $45.00 |
| Feb 17, 2022 | DA Davidson | Linda Bolton Weiser | Neutral | Maintains | $50.00 |
Nu Skin Enterprises Inc. (NUS) Competitors
The following stocks are similar to Nu Skin based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nu Skin Enterprises Inc. (NUS) Financial Data
Nu Skin Enterprises Inc. has a market capitalization of $369.12M with a P/E ratio of 72.7x. The company generates $1.68B in trailing twelve-month revenue with a -2.3% profit margin.
Revenue growth is -12.7% quarter-over-quarter, while maintaining an operating margin of +4.2% and return on equity of -4.9%.
Valuation Metrics
Market Cap
$369.12M
Enterprise Value
$483.38M
P/E Ratio
72.7x
PEG Ratio
7.2x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
-12.7%
Gross Margin
+67.8%
Operating Margin
+4.2%
Net Margin
-2.3%
EPS Growth
-12.7%
Financial Health
Cash/Price Ratio
+57.7%
Current Ratio
2.0x
Debt/Equity
43.8x
ROE
-4.9%
ROA
+3.5%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Nu Skin Enterprises Inc. (NUS) Business Model
About Nu Skin Enterprises Inc.
What They Do
Direct selling of premium personal care products.
Business Model
Nu Skin Enterprises employs a direct selling model that empowers individuals to operate personal businesses by marketing and distributing its range of beauty and wellness products. The company generates revenue through product sales made by its independent distributors, who earn commissions based on their sales performance and recruitment of new distributors.
Additional Information
Founded in 1984 and headquartered in Provo, Utah, Nu Skin has a global presence and is recognized for its focus on quality and sustainability. The company emphasizes scientific research in its product development, contributing to trends in nutraceuticals and personal care while maintaining a competitive edge in the direct selling industry.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
3,100
CEO
Mr. Ryan S. Napierski
Country
United States
IPO Year
1996
Website
www.nuskin.comNu Skin Enterprises Inc. (NUS) Latest News & Analysis
Latest News
Quick Summary
Nu Skin Enterprises, Inc. will hold its Q1 2025 Earnings Conference Call on May 8, 2025, at 5:00 PM ET, featuring key executives including the CEO and CFO.
Why It Matters
Nu Skin's upcoming Q1 2025 earnings call will provide insights into financial performance and strategic direction, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Nu Skin Enterprises (NYSE: NUS) reported Q1 2025 revenue of $364.5M, down 12.7% YoY. EPS was $2.14, up from $(0.01) YoY. Customer base decreased by 11%, with paid affiliates down 15%.
Why It Matters
Nu Skin's Q1 revenue beat expectations, signaling resilience despite declines in customer and affiliate numbers. Positive EPS growth indicates potential for recovery, affecting investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Nu Skin Enterprises, Inc. (NYSE: NUS) has declared a quarterly cash dividend of $0.06 per share, payable on June 11, 2025, to shareholders on record as of May 30, 2025.
Why It Matters
Nu Skin's quarterly dividend announcement signals financial stability and commitment to returning value to shareholders, potentially attracting income-focused investors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Nu Skin Enterprises, Inc. (NYSE: NUS) will release Q1 2025 results on May 8 after market close, followed by a conference call at 5 p.m. ET to discuss results and business initiatives.
Why It Matters
Nu Skin's upcoming earnings release and conference call provide insights into its financial health and future strategies, influencing stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Value stocks OPFI, NUS, BJRI, MRC, and KT were screened using the EV-to-EBITDA ratio to assess their valuation and earnings potential.
Why It Matters
The screening of value stocks based on the EV-to-EBITDA ratio highlights potential investment opportunities with favorable valuation and earnings prospects.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Nu Skin Enterprises (NUS) and Primo Brands (PRMB) have been compared to their sector performance for the year to date. Specific performance metrics were not provided in the excerpt.
Why It Matters
Performance comparisons reveal how Nu Skin and Primo Brands are faring against their sector, influencing investor sentiment and potential stock price movements.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About NUS Stock
What is Nu Skin Enterprises Inc.'s (NUS) stock forecast for 2025?
Analyst forecasts for Nu Skin Enterprises Inc. (NUS) are not currently available. The stock is trading at $7.58.
Is NUS stock a good investment in 2025?
According to current analyst ratings, NUS has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.58. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NUS stock?
Price predictions from Wall Street analysts for NUS are not currently available. The stock is trading at $7.58.
What is Nu Skin Enterprises Inc.'s business model?
Nu Skin Enterprises employs a direct selling model that empowers individuals to operate personal businesses by marketing and distributing its range of beauty and wellness products. The company generates revenue through product sales made by its independent distributors, who earn commissions based on their sales performance and recruitment of new distributors.
What is the highest forecasted price for NUS Nu Skin Enterprises Inc.?
Price targets from Wall Street analysts for NUS are not currently available. The stock is trading at $7.58.
What is the lowest forecasted price for NUS Nu Skin Enterprises Inc.?
Price targets from Wall Street analysts for NUS are not currently available. The stock is trading at $7.58.
What is the overall NUS consensus from analysts for Nu Skin Enterprises Inc.?
The overall analyst consensus for NUS is neutral. Out of 8 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are NUS stock price projections?
Stock price projections, including those for Nu Skin Enterprises Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 9:04 AM UTC